February 2025
2 days
English
800 USD/ person
Semmelweis University, Budapest, Hungary
Entry requirements:
Application deadline: 30 Jun, 2024
OVERVIEW

The course will cover the different genetic tests and technologies available for diagnosing rare diseases, such as PCR, real-time PCR, MLPA-based technologies, whole exome sequencing, and whole genome sequencing. During the course the clinical applications of genomics will be discussed, too.

This topic will focus on the use of genomics in clinical practice, including the interpretation of genetic test results, genetic counseling, and the integration of genomics into patient care. During the course the importance of rare disease registries and databases for improving the diagnosis and treatment of rare diseases will be discussed, as well as the challenges and opportunities associated with data sharing and privacy

In the seminar about precision medicine and targeted therapies participants will explore the potential of precision medicine and targeted therapies for treating rare diseases, including the use of gene therapy, cell therapy, and small-molecule drugs. Finally, we will address the ethical, legal, and social implications of clinical genetics and genomics in the diagnosis of rare diseases, including issues related to informed consent, genetic discrimination, and access to genetic testing and treatment.

The course is composed of 50 % theoretical part and 50 % practical part.

APPLY NOW

Entry requirements

Applicants are required to pay a registration fee before the course.

Registration fee: 80 USD

Participants’ limitation: min. 12 – max. 30

We would like to offer the participants the opportunity to share any interesting cases they may have with the program fellows during the course. So, if there is a case where genetic testing or its interpretation posed a challenge, there will be an opportunity to present and discuss it on three slides. The only request is that you kindly send the three slides for presentation a week before the program so that the lecturers can incorporate them into the program.

Required language proficiency

Advanced English knowledge

Learning objectives
  • Understanding the importance of  the role of clinical genetics/genomics in the rare disease diagnostic.
  • Getting aquinted with databases, ontologies, and the incorporation of web-based solutions in the development of medical hypotheses and clinical decision making (OMIM, ClinVar, DECIPHER, Orphanet, HPO, phenotype-driven gene prioritization). 
  • Learning about genetic tests frequently used in the rare disease diagnostic.
  • Raising awareness of the challenges of genetic testing.
  • Determin how to unlock genomic data.
  • Learning about personalized therapeutic decisions in clinical practice, and about the importance of NBS screening.
  • Figuring out how to build biobanks and rare disease registries, the role of the real-world data collection and data sharing in rare disorders.
  • Improving participants’ diagnostic skills. 

Application process

1. If you are interested in the course, please fill in the registration form or send us an application with your CV or LinkedIn profile via the following email: international@semmelweis.hu

2. Please wait until you receive an email confirmation from the program coordinator and an individual bank account number to pay the registration fee.

3. If you are interested in receiving an invoice or you have specific needs, please contact the program coordinator.

4. After receiving a confirmation from the program coordinator to participate in the selected course, you will be asked to pay the full course fee via the same bank account by the start of the course at the latest.

5. For our in-person courses, our colleagues can help you to recommend accommodations nearby the training venue and organise optional social activities in Budapest. If you need help, please feel free to contact them or check out our featured suggestions below. 

6. If you have any questions or inquiries, please feel free to get in touch with our colleagues.

APPLY NOW

Apply now